Akebia Therapeutics
AKBA
#6931
Rank
S$0.56 B
Marketcap
$2.61
Share price
-2.01%
Change (1 day)
108.80%
Change (1 year)

EPS for Akebia Therapeutics (AKBA)

EPS in 2023 (TTM): -$0.88

According to Akebia Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.86. In 2022 the company made an earnings per share (EPS) of -$0.68 an increase over its 2021 EPS that were of -$2.28.

EPS history for Akebia Therapeutics from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.8829.44%
2022-$0.68-70%
2021-$2.28-38.63%
2020-$3.7117.37%
2019-$3.162.79%
2018-$3.0831.2%
2017-$2.34-51.39%
2016-$4.8257.89%
2015-$3.05-94.83%
2014-$59.10589.75%
2013-$8.57

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$18.96-2,310.94%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.01-684.38%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$18.87-2,300.83%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.18 154.69%๐Ÿ‡บ๐Ÿ‡ธ USA